These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29947467)
1. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Gelu-Simeon M; Lewin M; Ostos M; Bayan T; Beso Delgado M; Teicher E; Layese R; Roudot-Thoraval F; Fontaine H; Sobesky R; Salmon-Céron D; Samuel D; Seror O; Nahon P; Meyer L; Duclos-Vallée JC; Liver Int; 2019 Jan; 39(1):136-146. PubMed ID: 29947467 [TBL] [Abstract][Full Text] [Related]
2. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. Lewin M; Gelu-Simeon M; Ostos M; Boufassa F; Sobesky R; Teicher E; Meyer L; Fontaine H; Salmon-Céron D; Samuel D; Seror O; Trinchet JC; Duclos-Vallée JC Radiology; 2015 Nov; 277(2):443-53. PubMed ID: 25961631 [TBL] [Abstract][Full Text] [Related]
3. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients. Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F; Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166 [TBL] [Abstract][Full Text] [Related]
5. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Bourcier V; Winnock M; Ait Ahmed M; Sogni P; Pambrun E; Poizot-Martin I; Chaffaut C; Chevret S; Trinchet JC; Salmon D; ; Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):214-21. PubMed ID: 22189509 [TBL] [Abstract][Full Text] [Related]
6. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C; J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185 [TBL] [Abstract][Full Text] [Related]
8. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response. Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617 [TBL] [Abstract][Full Text] [Related]
9. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Roudot-Thoraval F; Audureau E; Gastroenterology; 2018 Nov; 155(5):1436-1450.e6. PubMed ID: 30031138 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology. Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130 [TBL] [Abstract][Full Text] [Related]
12. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). Trinchet JC; Bourcier V; Chaffaut C; Ait Ahmed M; Allam S; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Buffet C; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Hillaire S; Di Martino V; Nahon P; Chevret S; Hepatology; 2015 Sep; 62(3):737-50. PubMed ID: 25678021 [TBL] [Abstract][Full Text] [Related]
13. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis. García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ; AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765 [TBL] [Abstract][Full Text] [Related]
14. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248 [TBL] [Abstract][Full Text] [Related]
15. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis. Merchante N; Rivero-Juárez A; Téllez F; Merino D; Ríos-Villegas MJ; Villalobos M; Omar M; Rincón P; Rivero A; Pérez-Pérez M; Raffo M; López-Montesinos I; Palacios R; Gómez-Vidal MA; Macías J; Pineda JA; J Antimicrob Chemother; 2018 Sep; 73(9):2435-2443. PubMed ID: 29982683 [TBL] [Abstract][Full Text] [Related]
16. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients. Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP; PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764 [TBL] [Abstract][Full Text] [Related]
17. Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals. Hasson H; Merli M; Messina E; Bhoori S; Salpietro S; Morsica G; Regalia E; Bagaglio S; Lazzarin A; Uberti-Foppa C; Mazzaferro V J Hepatol; 2017 Aug; 67(2):415-417. PubMed ID: 28411040 [No Abstract] [Full Text] [Related]
18. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Mourad A; Deuffic-Burban S; Ganne-Carrié N; Renaut-Vantroys T; Rosa I; Bouvier AM; Launoy G; Cattan S; Louvet A; Dharancy S; Trinchet JC; Yazdanpanah Y; Mathurin P Hepatology; 2014 Apr; 59(4):1471-81. PubMed ID: 24677195 [TBL] [Abstract][Full Text] [Related]
19. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G; Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811 [TBL] [Abstract][Full Text] [Related]
20. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients. Merchante N; Rodríguez-Fernández M; Figueruela B; Rodríguez-Arrondo F; Revollo B; Ibarra S; Téllez F; Merino E; Montero-Alonso M; Galindo MJ; Rivero-Juárez A; Santos IL; Delgado-Fernández M; García-Deltoro M; Vera-Méndez FJ; García MA; Aguirrebengoa K; Portu J; Ríos-Villegas MJ; Villalobos M; Alemán-Valls MR; Mínguez C; Galera C; Macías J; Pineda JA; AIDS; 2020 Aug; 34(10):1497-1507. PubMed ID: 32675563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]